These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 93697)

  • 1. [Diagnosis value of lipid content in prostatic cancer].
    Krajczár G; Szokol M
    Morphol Igazsagugyi Orv Sz; 1979 Oct; 19(4):282-6. PubMed ID: 93697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the prostatic puncture biopsy in the diagnosis of prostatic cancer. Apropos of 271 cases].
    Perrin P; Mouriquand P; Delorme E; Grisard M; Dutrieux-Berger N; Dassonville F
    J Urol (Paris); 1986; 92(9):601-4. PubMed ID: 2434575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
    Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
    Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytological diagnosis of nodular hyperplasia and cancer of the prostate].
    Mel'nik AN; Goĭkhberg MI; Klimanko IA; Levitskiĭ EO
    Vopr Onkol; 1983; 29(1):40-3. PubMed ID: 6186085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
    Belis JA
    Invest Urol; 1980 Jan; 17(4):332-6. PubMed ID: 6153177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 9. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia.
    Maygarden SJ; Strom S; Ware JL
    Arch Pathol Lab Med; 1992 Mar; 116(3):269-73. PubMed ID: 1371380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance.
    Shaikh N; Lai L; McLoughlin J; Clark D; Williams G
    Anticancer Res; 1990; 10(4):873-4. PubMed ID: 1696447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
    Rekhi B; Jaswal TS; Arora B
    Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma.
    Tomas D; Kruslin B
    Prostate; 2004 Dec; 61(4):324-31. PubMed ID: 15389817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic vasculitis in benign prostatic hyperplasia combined with a latent prostatic carcinoma].
    Shmurun RI
    Urol Nefrol (Mosk); 1997; (5):46-9. PubMed ID: 9412017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrectal fine needle aspiration of prostate.
    Jayaram G; Nakra N; Verma AK; Goel GD
    J Assoc Physicians India; 1993 Jun; 41(6):364-6. PubMed ID: 7516326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic squamous cell cancer and its differential diagnostic contrast with squamous cell metaplasia].
    Samsonov VA
    Arkh Patol; 1984; 46(8):23-9. PubMed ID: 6208883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology of prostatic cancer and its relationship to nodular hyperplasia.
    Pelova N
    Nauchni Tr Vissh Med Inst Sofiia; 1966; 45(6):59-68. PubMed ID: 4167357
    [No Abstract]   [Full Text] [Related]  

  • 20. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A; Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.